周一，Tempus AI 盘前大幅拉升。公司此前公布了2025年的初步业绩： 营收约为12.7亿美元，同比增长约 83%，其中不计Ambry业务，有机增长约30%。 分业务板块来看，诊断业务营收约为9.55亿美元，同比增长约111%，主要得益于肿瘤检测量增长约 26%和遗传检测量增长约29%。 同时，Tempus 预计 2025 年净收入留存率约为 126%。 管理层评论 Tempus 创始人兼首席执行官 Eric Lefkofsky声明称："在诊断业务方面，我们的基因组学（肿瘤学） 产品销量同比增长连续第三个季度加速，达到多年来的最高增长率。" "我们两大核心业务均加速增长，并充分发挥了我们平台固有的财务杠杆作用，因此我们以极其强劲的 势头进入2026年。人工智能将作为我们所有产品的催化剂，我们对2026年充满信心。" Tempus AI 第四季度营收约为 3.67 亿美元，同比增长 83%。其中，诊断业务营收约为 2.66 亿美元 （同比增长 121%），主要得益于肿瘤检测业务量增长约 29% 和基因检测业务量增长约 23%。 此外，数据和应用业务营收为 1 亿美元，同比增长 25%。若不计入 2024 ...

Core Insights - Eddycon Holdings (09860) reported annual results for the year ending December 31, 2024, with revenue of 2.914 billion RMB and a net profit attributable to shareholders of 47.014 million RMB, translating to earnings per share of 0.07 RMB [1] Group 1: Financial Performance - The company's regular business revenue, excluding COVID-19 related income, grew by 8.2%, driven by strong growth in specialty testing services, which saw an increase of over 18% compared to the same period in 2023 [1] - Revenue from collaborative business initiatives increased by 62% year-on-year, significantly broadening market coverage and enhancing service offerings [1] Group 2: Technological Advancements - The company upgraded its laboratory systems, including the next-generation LIMS, OMS, reporting platform, PIMS, and logistics systems, aiming to enhance operational efficiency and service quality [2] - The application of artificial intelligence (AI) technology has been expanded, with over 8 million images analyzed, improving diagnostic efficiency and accuracy [2] Group 3: Operational Efficiency - The company implemented various cost control measures, achieving a 10% reduction in reagent procurement costs and a 6% reduction in logistics costs compared to 2023 [3] - The company enhanced labor efficiency in laboratory management by 7% year-on-year, optimizing resource allocation and personnel scheduling [3] - The total number of ISO15189 accredited laboratories increased to 23, with the Hangzhou laboratory achieving a leading 320 accredited testing items, ensuring high service quality and market competitiveness [3]